New insider Anderson Cory claimed ownership of 416,812 shares (SEC Form 3)
$STIM
Medical/Dental Instruments
Health Care
| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 07/01/2026 | 3. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 53,205 | D | |
| Common Stock | 13,336(1) | D | |
| Common Stock | 5,001(2) | D | |
| Common Stock | 3,334(3) | D | |
| Common Stock | 55,003(4) | D | |
| Common Stock | 136,933(5) | D | |
| Common Stock | 150,000(6) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Performance Restricted Stock Unit | 12/31/2026(7) | 12/31/2027(7) | Common Stock | 18,335(7) | $0(8) | D | |
| Performance Restricted Stock Unit | 12/31/2026(9) | 12/31/2026(9) | Common Stock | 15,000(9) | $0(8) | D | |
| Explanation of Responses: |
| 1. Represents a restricted stock unit ("RSU") award that vests on February 5, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2. Represents a RSU award that vests on February 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 3. Represents a RSU award that vests on March 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 4. Represents a RSU award that vests in two equal annual installments beginning on February 24, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 5. Represents a RSU award that vests on June 30, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 6. Represents a RSU award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 7. Represents a performance restricted stock unit ("PRSU") award granted on February 24, 2025 and vesting beginning on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 50% of the award will be attained if the Issuer achieves Cash Balance (as defined in the applicable PRSU grant notice) for the fiscal year ended 2026 and (ii) 50% of the award will be attained if the Issuer achieves Cash Balance for the fiscal year ended 2027. |
| 8. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. |
| 9. Represents a PRSU award granted on October 29, 2025 and vesting on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended September 30, 2026. |
| /s/ Patrick Devine, as Attorney-in-Fact | 07/13/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||